# Epigenetic–Genetic Coupling and Understanding the Molecular and Cellular Basis of Lamarckian Inheritance

**Authors:** Robyn A. Lindley, Reginald M. Gorczynski, Edward J. Steele

PMC · DOI: 10.3390/ijms27042003 · International Journal of Molecular Sciences · 2026-02-20

## TL;DR

This paper explores how acquired traits might be inherited through epigenetic and genetic mechanisms, offering a new perspective on Lamarckian inheritance.

## Contribution

The paper introduces the concept of epigenetic–genetic coupling as a potential mechanism for Lamarckian inheritance in mammals.

## Key findings

- Reverse transcriptase activity of DNA polymerase η supports RNA-to-DNA genetic feedback.
- Inbreeding and environmental stimuli may be necessary for stable Lamarckian inheritance.
- Long-read genomic sequencing can help identify molecular evidence of acquired inheritance.

## Abstract

This critical and selective review synthesizes the accumulating body of biological evidence supporting a process we term epigenetic–genetic coupling as a mechanistic basis for Lamarckian inheritance of somatically acquired adaptations. We propose that evolutionary processes in mammals and higher vertebrates can involve deaminase-driven, reverse transcriptase-mediated, RNA-templated targeted homologous recombination. We contrast well-established examples of “Soft”, reversible epigenetic inheritance with historical and contemporary evidence suggestive of stable, DNA-integrated “Hard” Lamarckian transgenerational inheritance. Our analysis indicates that the establishment of “Hard” Lamarckian inheritance may require specific population dynamics, including inbreeding or interbreeding among phenotypically affected offspring, together with sustained and defined environmental stimuli over one or more generations to consolidate the acquired traits at the genomic level. We also present molecular and cellular evidence supporting RNA-to-DNA genetic feedback mechanisms involving targeted genomic integration, primarily mediated by the DNA repair–associated reverse transcriptase activity of DNA polymerase η. Finally, we review diversification mechanisms in molecular and cellular immunology that now routinely employ single-molecule, real-time, long-read genomic sequencing (6–8 kb). We recommend the broader application of these technologies in future breeding and experimental programs across other somatic systems. Their deployment offers a robust strategy for securing definitive “Hard” molecular evidence of Lamarckian acquired inheritance in diverse biological contexts; including somatically acquired immunity, as well as adaptive behavioral and central nervous system phenotypes. This is compatible with our over-arching goal—to provide an experimental road map of conceptual options to drive future experimentation in acquired inheritance breeding programs.

## Full-text entities

- **Genes:** POLH (DNA polymerase eta) [NCBI Gene 5429] {aka RAD30, RAD30A, XP-V, XPV}, Igk-V (immunoglobulin kappa chain complex variable region) [NCBI Gene 16080], HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, Kit (Kit proto-oncogene receptor tyrosine kinase) [NCBI Gene 16590] {aka Bs, CD117, Fdc, Gsfsco1, Gsfsco5, Gsfsow3}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, IGHD (immunoglobulin heavy constant delta) [NCBI Gene 3495], IGH (immunoglobulin heavy locus) [NCBI Gene 3492] {aka IGD1, IGH.1@, IGH@, IGHD@, IGHDY1, IGHJ}, APOBEC3A (apolipoprotein B mRNA editing enzyme catalytic subunit 3A) [NCBI Gene 200315] {aka A3A, ARP3, PHRBN, bK150C2.1}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, IGHV3-75 (immunoglobulin heavy variable 3-75 (pseudogene)) [NCBI Gene 28407] {aka 3-75P, IGHV375, VH3}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, AICDA (activation induced cytidine deaminase) [NCBI Gene 57379] {aka AID, ARP2, CDA2, HEL-S-284, HIGM2}, ADAR (adenosine deaminase RNA specific) [NCBI Gene 103] {aka ADAR1, AGS6, DRADA, DSH, DSRAD, G1P1}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, Ighm (immunoglobulin heavy constant mu) [NCBI Gene 16019] {aka Igh-6, Igh-M, Igh6, Igm, TC1460681, muH}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}, Igha (immunoglobulin heavy constant alpha) [NCBI Gene 238447] {aka IgA, Igh-2}, ADARB1 (adenosine deaminase RNA specific B1) [NCBI Gene 104] {aka ADAR2, DRABA2, DRADA2, NEDHYMS, RED1}, Igh-V (immunoglobulin heavy chain variable region) [NCBI Gene 16049] {aka B1H12, B4H2, Gal13, IGHV2B, M86}
- **Diseases:** Cancer (MESH:D009369), COVID-19 (MESH:D000086382), Diabetes (MESH:D003920), Eye Defects (MESH:D005124), ocular malformations (MESH:D015817), hyperglycemia (MESH:D006943), SHM (MESH:D013001), injury to (MESH:D014947), glucose intolerance (MESH:D018149), metabolic disorder (MESH:D008659), Mendelian Inheritance in Man (MESH:D030342), Rabbit plague (MESH:D010930), metabolic and hormonal disorders (MESH:C566454), autoimmune (MESH:D001327)
- **Chemicals:** pseudouridine (MESH:D011560), saccharin (MESH:D012439), uracil (MESH:D014498), Alloxan (MESH:D000496), 8oxoG (-), ROS (MESH:D017382), cyclophosphamide (MESH:D003520), blood glucose (MESH:D001786), Glucose (MESH:D005947), cytosine (MESH:D003596), STZ (MESH:D013311), U (MESH:D014501), lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Canis lupus familiaris (dog, subspecies) [taxon 9615], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Ovis aries (domestic sheep, species) [taxon 9940], Cavia porcellus (domestic guinea pig, species) [taxon 10141]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941027/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941027/full.md

## References

115 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941027/full.md

---
Source: https://tomesphere.com/paper/PMC12941027